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ABSTRACT. Accumulation of hydrogen peroxide (H2O2) and low 
catalase (CAT) activity have been demonstrated in the epidermis of 
vitiligo patients. We investigated a possible association between the 
CAT exon 9 (Asp-389) gene and vitiligo susceptibility in the Turkish 
population. Thirty-four patients with vitiligo and 49 gender, age and 
ethnic matched controls were enrolled in the study. Genotyping was 
done by PCR-RFLP. The CAT exon 9 (Asp-389) genotype and allele 
frequencies of vitiligo patients did not differ significantly from those of 
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healthy controls. We found no association between CAT (Asp-389) gene 
polymorphism and vitiligo susceptibility in Turkish vitiligo patients.
Key words: Melanocytes; Oxidative stress catalase gene (CAT);
PCR-RFLP; Vitiligo
INTRODUCTION
Vitiligo (MIM193200) is the most common depigmentation disorder of the skin and 
hair that results from a selective destruction of melanocytes (Hann and Nordlund, 2000). It has 
been reported that vitiligo can affect all populations worldwide with diverse prevalence rates 
ranging from 0.1 to 2% in different geographical regions and ethnic groups (Hafez et al., 1983; 
Das et al., 1985a; Hann and Nordlund, 2000; Alkhateeb et al., 2003).
The etiology of vitiligo is still unknown, although the disease was first noted in ap-
proximately 1500 B.C. (Hann and Nordlund, 2000). Several theories have been proposed to 
explain the pathogenesis of vitiligo, including self-destructive, biochemical, neural, auto-
immune and genetic hypotheses (Hann and Nordlund, 2000). Epidemiological studies have 
shown that vitiligo tends to aggregate in families (Das et al., 1985b; Majumder et al., 1993; 
Nath et al., 1994; Barona et al., 1995; Alkhateeb et al., 2003; Zhang et al., 2004a). About 20% 
of vitiligo patients have at least one first-degree relative with vitiligo. The relative risk of de-
veloping vitiligo is increased 7- to 10-fold in first degree relatives of vitiligo patients (Nath et 
al., 1994).
The familial aggregation of vitiligo has been noted as early as 1933 (Hann and 
Nordlund, 2000). In order to clarify the genetic and environmental contributions to the 
familial character of the disease, epidemiological surveys have been conducted in many 
countries and various ethnic populations (Mehta et al., 1973; Howitz et al., 1977; Nordlund, 
1997; Majumder et al., 1993; Nath et al., 1994; Alkhateeb et al., 2003; Zhang et al., 2004b). 
Although vitiligo clusters in families, it does not appear to segregate in a simple Mendelian 
pattern (Majumder et al., 1988, 1993; Nath et al., 1994; Alkhateeb et al., 2003). The aggre-
gation of vitiligo in families observed in several studies suggests that vitiligo is a genetically 
or environmentally determined disease (Das et al., 1985b; Majumder et al., 1993; Nath et 
al., 1994). The complex genetics of vitiligo probably involves multiple susceptibility loci, 
genetic heterogeneity and incomplete penetrance with gene-gene and gene-environment in-
teractions (Zhang et al., 2005). Increasing number of studies have demonstrated that certain 
genes are crucial for the development of vitiligo (Le Poole et al., 2001; Arcos-Burgos, 2002; 
Casp et al., 2002, 2003; Zhang et al., 2004a; Jin et al., 2004; Yang et al., 2005). Moreover, 
more than one genome-wide screen has localized vitiligo susceptibility loci on several chro-
mosomes (Alkhateeb, 2002; Fain et al., 2003; Spritz et al., 2004; Chen et al., 2005).
Studies have demonstrated that the amount of hydrogen peroxide (H202) in the skin 
of patients with vitiligo is significantly higher compared to the control group, while catalase 
enzyme activity is lower (Schallreuter et al., 1999). Other studies have also demonstrated the 
accumulation of H2O2 and low catalase activity in the epidermis of vitiligo patients (Schallreuter 
et al., 1991; Maresca et al., 1997). Catalase is the enzyme that catalyzes the conversion of hy-
drogen peroxide to water and oxygen, thereby preventing cellular damage due to highly reactive 
oxygen-derived free radicals. The CAT gene was selected as a candidate gene because of the 
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reduction of catalase enzyme activity and concomitant accumulation of excess hydrogen 
peroxide observed in the entire epidermis of vitiligo patients (Schallreuter et al., 1999). The 
CAT gene consists of 13 exons spanning 34 kb of genomic DNA located at 11p13 with the 
complete cDNA sequence revealing a coding region of 1581 base pairs in length (Bell et al., 
1986). An association has been established between vitiligo and a single nucleotide poly-
morphism (SNP) in exon 9 of the CAT gene (Casp et al., 2002). It has been documented that 
T/C heterozygotes are more frequent among vitiligo patients than controls, and that the C 
allele is transmitted more frequently to patients with vitiligo compared to controls, suggest-
ing that linked mutations in or near the CAT gene may contribute to a quantitative deficiency 
of catalase activity in the epidermis and accumulation of excess hydrogen peroxide (Casp 
et al., 2002).
Earlier, the T/C SNP in exon 9 of the CAT gene was found to be informative in 
terms of the DNA analysis of Caucasian vitiligo patients and control subjects. This region 
contains hidden changes which constitute informative gene markers for the catalase gene. 
Asp-389 is coded by both GAU and GUC, and thus the T/C difference in the gene sequence 
does not change the amino acid sequence. The objective of this study was to determine a 
possible association between the CAT gene and vitiligo susceptibility in a Turkish popula-
tion using this marker.
MATERIAL AND METHODS
Study participants
Thirty-four Turkish vitiligo patients (14 men and 20 women) were examined at the 
Department of Dermatology, Ege University Medical Faculty. Family history of vitiligo was 
present in 25% of the patients with vitiligo. Forty-nine sex-, age- and ethnicity-matched sub-
jects without any clinical evidence of vitiligo were enrolled in the control group. The study 
was approved by the local institutional ethics committee and was conducted according to the 
Declaration of Helsinki of 1975. All participants were informed about the nature of the study, 
and written informed consent was obtained.
Catalase gene polymorphisms
SNP was identified in a T/C polymorphism in exon 9 (NCBI, dbSNP number 
rs769217) (Park et al., 2006). DNA samples were isolated from blood samples obtained 
from 34 vitiligo patients and 49 healthy controls using the King Fisher Genomic DNA 
Purification kit. Samples (100 ng) were submitted to 35 amplification cycles in a Perkin 
Elmer GeneAmp PCR system 9600 amplification machine, where each cycle consisted of 
denaturation at 94°C for 30 s, annealing for 30 s and extension at 72°C for 30 s, and a final 
extension step of incubation at 72°C for 5 min. Following an overnight restriction digestion 
of the PCR products under the conditions specified by the enzyme supplier, DNA fragments 
were separated by 3% agarose gel electrophoresis and stained with ethidium bromide (Park 
et al., 2006).
The allele discrepancies in the series of PCR products were evaluated using the re-
striction enzyme (BstX1) (CCANNNNNNTGG). The prepared mixture (12 mL PCR product, 
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mL buffer, 2.5 mL BstX1) was put in a 0.5 mL Eppendorf tube and sealed with paraffin. After 
a short period of centrifugation, the mixture was incubated for 16 h at 55°C. Cutting occurred 
if the CAT gene was a T allele; however, no cutting occurred in the case of a C allele. In the 
latter case (homozygous C), no change was observed in the size of this DNA piece. In the 
former case where enzyme cutting occurred, the 202-bp DNA fragment was cut into two parts 
of 98 and 104 bp. The homozygous T allele was differentiated by the strong appearance of 
these bands.
Statistical analysis
Distribution of the genotypes in patient and control groups was compared using the 
chi-square (χ2) test. Hardy-Weinberg equilibrium (HWE) was determined using the test pro-
vided by the Institute of Human Genetics, Technical University Munich (http://ihg.gsf.de/cgi.
bin/hw/hwa1.pl). P values <0.05 were considered statistically significant. 
RESULTS 
The allele and genotype frequencies of the single nucleotide polymorphism (T/C) in 
the 9th exon of the catalase gene of the control and patient groups are shown in Table 1. In 
the comparison of allele frequencies between the control and patient groups, no significant 
difference was found in the exon Bstx1 (T/C) polymorphism in the catalase gene (P = 0.20). 
No significant difference was found between the genotypic frequencies of the control and 
patient groups determined by the expected value of the χ2-test as shown in Table 1. Similarly, 
there were no significant differences in the comparison of genotypic frequencies of the control 
and the patient groups (P = 0.09). The ratio of heterozygote and homozygotes in the entire 
population was calculated theoretically using the Hardy-Weinberg equation. Values obtained 
from the Hardy-Weinberg equation were 64% for CC homozygotes (0.8 x 0.8 = 64), 32% for 
CT heterozygotes (0.8 x 0.2 x 0.2 = 0.32), and 4% for TT homozygotes (0.2 x 0.2 = 0.04). 
The genetic allele frequencies of the patient populations showed a significant deviation from 
Hardy-Weinberg equilibrium.
CAT gene (Asp-389) Control (N = 49) Vitiligo (N = 34) P
Genotypes
   CC  43 (87.7)  28 (82.3) 0.086
   CT    6 (12.3)   4 (11.8) 0.972
   TT 0 (0)  2 (5.9) 0.121
   CC+CT 49 (100)  32 (94.1) 0.085
   CT+TT    6 (12.3)    6 (17.6) 0.491
   Total 49 (100) 34 (100)
Alleles
   C  92 (93.9)  60 (88.2) 0.198
   T  6 (6.1)    8 (11.8)
   Total 98 (100) 68 (100)
*HWE p 0.648 0.011
Data are reported as number with percent in parentheses. *HWE = Hardy-Weinberg equilibrium, 
Table 1. Genotype and allele frequencies of the catalase gene (Asp-389) polymorphism in patients with vitiligo 
and controls.
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DISCUSSION
The relationship between the polymorphisms of the catalase enzyme and various 
diseases have been investigated (Góth et al., 2001). The C/T endemic polymorphism in the 
initial part of the catalase enzyme is effective in binding transcription factors. In a study per-
formed in the Swedish population using a restriction enzyme, the T allele frequency was been 
found to be 28%, and the catalase enzyme activity was found to be higher in the groups with 
the T allele compared to groups with the C allele (P < 0.03) (Forsberg et al., 2001).
Although it has been observed that a single (T/C) nucleotide polymorphism in the 
9th exon of the catalase enzyme may be considered to have a role in the disposition for vit-
iligo (Casp et al., 2002; Park et al., 2006; Gavalas et al., 2006; Em et al., 2007), there are no 
studies that have investigated the role of this polymorphism in the etiology of vitiligo in the 
Turkish population.
Casp et al. (2002) reported an association between susceptibility to vitiligo and a C/T 
SNP in codon 389 of the CAT gene in a North American population. Gavalas et al. (2006) 
suggested that the CAT gene C/T SNP is associated with susceptibility to vitiligo, with the 
C/T genotype being significantly more frequent among vitiligo patients compared to healthy 
controls. However, it has not yet been established how the CAT gene C/T SNP could result 
in low catalase levels, and it is unlikely to affect the catalase activity directly since the varia-
tion results in a silent substitution of the aspartate residue at codon 389. Alternatively, this 
genetic marker could be linked to other CAT mutations that are deleterious in terms of the 
expression of CAT or the activity of catalase (Gavalas et al., 2006). The distribution of CAT 
gene genotype and allele frequencies have not been shown to differ significantly between 
vitiligo patients and normal controls, and the difference in haplotype distribution of catalase 
between vitiligo patients and normal controls has suggested a possible relationship between 
CAT gene and vitiligo susceptibility (Park et al., 2006). Em et al. (2007) showed that the 
well-documented CAT exon 9 T⁄C may not be associated with Gujarat vitiligo patients.
Lv et al. (2011) found a significant correlation between the CAT T⁄C exon 9 poly-
morphism and the risk of vitiligo. Casp et al. (2002) and Gavalas et al. (2006) demon-
strated an association between vitiligo susceptibility and CAT T⁄C SNP at codon 389 in 
Caucasian and English populations, respectively. However, in Korean (Park et al., 2006) 
and Gujarat (Em et al., 2007) populations, the distribution of T⁄C CAT exon 9 genotype 
and allele frequencies were not significantly associated with vitiligo which is in accor-
dance with the results of our study.
In conclusion, we suggest that the enzyme catalase is involved in a genetic effect in 
vitiligo. Further studies should be performed with greater sample size to verify these results. 
Studies performed with catalase have shown that reformation of pigments is important in 
preventing vitiligo. Although the exact role of catalase in the development of vitiligo is not 
yet known, catalase is has been proven to have an effect in the treatment of this disease. 
Therefore, further studies should be performed with this enzyme to elucidate its role in the 
pathogenesis of vitiligo.
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